Short-term aerobic exercise for depression in acute geriatric psychiatry: study protocol for a randomized controlled trial.
Endurance training
Hospital-setting
Intervention
Old-age depression
RCT
Journal
Trials
ISSN: 1745-6215
Titre abrégé: Trials
Pays: England
ID NLM: 101263253
Informations de publication
Date de publication:
30 Jul 2022
30 Jul 2022
Historique:
received:
04
03
2022
accepted:
19
07
2022
entrez:
30
7
2022
pubmed:
31
7
2022
medline:
3
8
2022
Statut:
epublish
Résumé
Major depression is one of the main mental illnesses in old age, with acute exacerbated episodes requiring treatment in geriatric psychiatry. A meta-analysis showed that aerobic exercise in moderate intensity has large effects in older adults with major depression, but there is no evidence of aerobic exercise in geriatric psychiatry. Therefore, this study aims to analyze the feasibility and effects of an ergometer-based aerobic exercise on depressive symptoms. A single-center randomized controlled trial will be conducted in an acute geriatric psychiatric hospital. Inpatients allocated to the intervention group will receive a 2-week aerobic ergometer program. The control group will receive seated flexibility exercise in addition to usual care. The overall effects on the patients' depressive symptoms will be measured by clinical global impression of change (CGI) as the primary outcome. Changes in depressive symptom domains, physical (in)activity, and aerobic performance as well as the dosage of applied antidepressants will be examined as secondary outcomes. This short-term aerobic exercise program is expected to decrease depressive symptoms in acute exacerbated periods in older adults. The results may increase the evidence for implementing physical activity interventions in acute hospital settings. The disease-related motivation for exercise in acute exacerbated depressive periods will be the most challenging aspect. The treatment of depression requires new cost-effective approaches, especially in acute geriatric psychiatry with potential benefits for patients, family members, and clinicians. German Clinical Trial Register ID: DRKS00026117 TRIAL STATUS: Protocol Version 1.2 dated February 23, 2022. By February 23, 2022, the trial had recruited a total of 15 participants in two wards at the Department of Geriatric Psychiatry at the LVR-Hospital Cologne. Recruitment started on November 12, 2021. The recruitment is expected to continue for at least 12 months.
Sections du résumé
BACKGROUND
BACKGROUND
Major depression is one of the main mental illnesses in old age, with acute exacerbated episodes requiring treatment in geriatric psychiatry. A meta-analysis showed that aerobic exercise in moderate intensity has large effects in older adults with major depression, but there is no evidence of aerobic exercise in geriatric psychiatry. Therefore, this study aims to analyze the feasibility and effects of an ergometer-based aerobic exercise on depressive symptoms.
METHODS
METHODS
A single-center randomized controlled trial will be conducted in an acute geriatric psychiatric hospital. Inpatients allocated to the intervention group will receive a 2-week aerobic ergometer program. The control group will receive seated flexibility exercise in addition to usual care. The overall effects on the patients' depressive symptoms will be measured by clinical global impression of change (CGI) as the primary outcome. Changes in depressive symptom domains, physical (in)activity, and aerobic performance as well as the dosage of applied antidepressants will be examined as secondary outcomes.
DISCUSSION
CONCLUSIONS
This short-term aerobic exercise program is expected to decrease depressive symptoms in acute exacerbated periods in older adults. The results may increase the evidence for implementing physical activity interventions in acute hospital settings. The disease-related motivation for exercise in acute exacerbated depressive periods will be the most challenging aspect. The treatment of depression requires new cost-effective approaches, especially in acute geriatric psychiatry with potential benefits for patients, family members, and clinicians.
TRIAL REGISTRATION
BACKGROUND
German Clinical Trial Register ID: DRKS00026117 TRIAL STATUS: Protocol Version 1.2 dated February 23, 2022. By February 23, 2022, the trial had recruited a total of 15 participants in two wards at the Department of Geriatric Psychiatry at the LVR-Hospital Cologne. Recruitment started on November 12, 2021. The recruitment is expected to continue for at least 12 months.
Identifiants
pubmed: 35908008
doi: 10.1186/s13063-022-06567-4
pii: 10.1186/s13063-022-06567-4
pmc: PMC9338474
doi:
Types de publication
Clinical Trial Protocol
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
615Informations de copyright
© 2022. The Author(s).
Références
Am J Geriatr Psychiatry. 2001 Spring;9(2):113-35
pubmed: 11316616
Front Psychol. 2020 May 06;11:857
pubmed: 32435223
Med Sci Sports Exerc. 1982;14(5):377-81
pubmed: 7154893
J Neurol Neurosurg Psychiatry. 1960 Feb;23:56-62
pubmed: 14399272
Appl Nurs Res. 2020 Feb;51:151189
pubmed: 31672262
Br J Psychiatry. 2012 Sep;201(3):180-5
pubmed: 22945926
J Psychiatry Neurosci. 2006 Mar;31(2):84-92
pubmed: 16575423
World Psychiatry. 2006 Oct;5(3):139-45
pubmed: 17139340
Trends Neurosci. 2002 Jun;25(6):295-301
pubmed: 12086747
Eur J Epidemiol. 2013 Mar;28(3):249-56
pubmed: 23338904
J Affect Disord. 2012 Feb;136(3):212-21
pubmed: 21194754
J Am Geriatr Soc. 2011 Feb;59(2):266-73
pubmed: 21314647
Arch Gen Psychiatry. 1961 Jun;4:561-71
pubmed: 13688369
Maturitas. 2014 Sep;79(1):91-5
pubmed: 25022468
Ann Intern Med. 1990 Dec 15;113(12):941-8
pubmed: 2240918
J Am Geriatr Soc. 2008 Dec;56(12):2171-9
pubmed: 19093915
J Psychiatr Res. 1975 Nov;12(3):189-98
pubmed: 1202204
J Am Geriatr Soc. 2002 May;50(5):889-96
pubmed: 12028177
Transl Psychiatry. 2019 Aug 5;9(1):188
pubmed: 31383842
Int J Behav Nutr Phys Act. 2020 May 25;17(1):69
pubmed: 32450879
J Affect Disord. 2015 Jul 15;180:179-84
pubmed: 25911132
Ann Clin Res. 1971 Dec;3(6):404-32
pubmed: 4945367
Sports Med. 2016 May;46(5):699-713
pubmed: 26707338
J Affect Disord. 2016 Feb;191:139-44
pubmed: 26655860
Pharmacopsychiatry. 1999 Sep;32(5):165-8
pubmed: 10543377
J Am Geriatr Soc. 1991 Feb;39(2):142-8
pubmed: 1991946
Br J Sports Med. 2007 Jan;41(1):29-33
pubmed: 17062659
J Health Soc Behav. 2006 Dec;47(4):355-72
pubmed: 17240925
J Neural Transm. 1989;78(2):121-30
pubmed: 2478662
Lancet. 2016 Oct 8;388(10053):1603-1658
pubmed: 27733283
N Engl J Med. 2008 Jan 3;358(1):55-68
pubmed: 18172175
Int J Geriatr Psychiatry. 2019 Feb;34(2):308-314
pubmed: 30403307
Sensors (Basel). 2020 Mar 28;20(7):
pubmed: 32231041
Scand J Med Sci Sports. 2020 May;30(5):816-827
pubmed: 32020713
Int J Neuropsychopharmacol. 2010 Jun;13(5):595-602
pubmed: 20067661
F1000Res. 2020 Nov 13;9:1325
pubmed: 34158928
Pharmacol Res. 2018 Apr;130:374-384
pubmed: 29438781
Clin Pract Epidemiol Ment Health. 2013 Jul 12;9:125-35
pubmed: 24009640
Braz J Psychiatry. 2016 Jul-Sep;38(3):247-54
pubmed: 27611903
Behav Res Methods. 2007 May;39(2):175-91
pubmed: 17695343
J Clin Psychiatry. 2000;61 Suppl 6:7-11
pubmed: 10775018
J Gerontol A Biol Sci Med Sci. 2003 Mar;58(3):249-65
pubmed: 12634292
Wien Med Wochenschr. 2011 Sep;161(17-18):416-25
pubmed: 21792532
Psychiatry Res. 1997 Dec 5;73(3):159-71
pubmed: 9481807